Your browser doesn't support javascript.
loading
External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia.
Rees, Chris A; Hooli, Shubhada; King, Carina; McCollum, Eric D; Colbourn, Tim; Lufesi, Norman; Mwansambo, Charles; Lazzerini, Marzia; Madhi, Shabir Ahmed; Cutland, Clare; Nunes, Marta; Gessner, Bradford D; Basnet, Sudha; Kartasasmita, Cissy B; Mathew, Joseph L; Zaman, Syed Mohammad Akram Uz; Paranhos-Baccala, Glaucia; Bhatnagar, Shinjini; Wadhwa, Nitya; Lodha, Rakesh; Aneja, Satinder; Santosham, Mathuram; Picot, Valentina S; Sylla, Mariam; Awasthi, Shally; Bavdekar, Ashish; Pape, Jean-William; Rouzier, Vanessa; Chou, Monidarin; Rakoto-Andrianarivelo, Mala; Wang, Jianwei; Nymadawa, Pagbajabyn; Vanhems, Philippe; Russomando, Graciela; Asghar, Rai; Banajeh, Salem; Iqbal, Imran; MacLeod, William; Maulen-Radovan, Irene; Mino, Greta; Saha, Samir; Singhi, Sunit; Thea, Donald M; Clara, Alexey W; Campbell, Harry; Nair, Harish; Falconer, Jennifer; Williams, Linda J; Horne, Margaret; Strand, Tor.
Afiliação
  • Rees CA; Division of Pediatric Emergency Medicine, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Hooli S; Section of Pediatric Emergency Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • King C; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden and Institute for Global Health, University College London, London, UK.
  • McCollum ED; Global Program in Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, USA and Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
  • Colbourn T; Institute for Global Health, University College London, London, UK.
  • Lufesi N; Ministry of Health, Lilongwe, Malawi.
  • Mwansambo C; Ministry of Health, Lilongwe, Malawi.
  • Lazzerini M; WHO Collaborating Centre for Maternal and Child Health, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
  • Madhi SA; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Disea
  • Cutland C; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Disea
  • Nunes M; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Disea
  • Gessner BD; Pfizer Vaccines, Collegeville, Pennsylvania, USA.
  • Basnet S; Center for Intervention Science in Maternal and Child Health, University of Bergen, Norway.
  • Kartasasmita CB; Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
  • Mathew JL; Pediatric Pulmonology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Zaman SMAU; Liverpool School of Tropical Medicine, Liverpool, UK.
  • Paranhos-Baccala G; Fondation Merieux, Lyon, France.
  • Bhatnagar S; Translational Health Science and Technology Institute, Faridabad, India.
  • Wadhwa N; Translational Health Science and Technology Institute, Faridabad, India.
  • Lodha R; All India Institute of Medical Sciences, New Delhi, India.
  • Aneja S; School of Medical Sciences & Research, Sharda University, Greater Noida, India.
  • Santosham M; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
  • Picot VS; Fondation Merieux, Lyon, France.
  • Sylla M; Gabriel Touré Hospital, Department of Pediatrics, Bamako, Mali.
  • Awasthi S; King George's Medical University, UP, Department of Pediatrics, Lucknow, India.
  • Bavdekar A; KEM Hospital Pune, Department of Pediatrics, Pune, India.
  • Pape JW; GHESKIO, Centre GHESKIO, Port au Prince, Haiti.
  • Rouzier V; GHESKIO, Department of Pediatrics, Port au Prince, Haiti.
  • Chou M; University of Health Sciences Faculty of Medicine, Rodolph Mérieux Laboratory, Phom Phen, Cambodia.
  • Rakoto-Andrianarivelo M; Centre d'Infectiologie Charles Mérieux, Antanarivo, Madagascar.
  • Wang J; Chinese Academy of Medical Sciences & Peking Union, Medical College Institute of Pathogen Biology, MOH Key Laboratory of Systems Biology of Pathogens and Dr Christophe Mérieux Laboratory, Beijing, China.
  • Nymadawa P; Mongolian Academy of Sciences, Academy of Medical Sciences, Ulaanbaatar, Mongolia.
  • Vanhems P; Hospices Civils de Lyon, Infection Control Unit; CIRI, Centre International de Recherche en Infectiologie, (Team PHE3ID), Université Claude Bernard Lyon, Lyon, France.
  • Russomando G; Universidad Nacional de Asuncion, Instituto de Investigaciones en Ciencias de la Salud, San Lorenzo, Paraguay.
  • Asghar R; Rawalpindi Medical College, Rawalpindi, Pakistan.
  • Banajeh S; Sana'a University, Sana'a, Yemen.
  • Iqbal I; Nishtar Medical College, Multan, Pakistan.
  • MacLeod W; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Maulen-Radovan I; Instituto Nactional de Pediatria Division de Investigacion Insurgentes, Mexico City, Mexico.
  • Mino G; Children's Hospital Dr Francisco de Ycaza Bustamante, Head of Department, Infectious diseases, Guayaquil, Ecuador.
  • Saha S; Dhaka Shishu Hospital, Dhaka, Bangladesh.
  • Singhi S; Medanta, The Medicity, Gurgaon, India.
  • Thea DM; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Clara AW; US Centers for Disease Control, Central American Region, Guatemala City, Guatemala.
  • Campbell H; Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, Scotland.
  • Nair H; Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, Scotland.
  • Falconer J; Institute for Global Health and Development, Queen Margaret University, Edinburgh, Scotland.
  • Williams LJ; Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, Scotland.
  • Horne M; Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, Scotland.
  • Strand T; Research Department, Innlandet Hospital Trust, Lillehammer, Norway.
J Glob Health ; 11: 04062, 2021.
Article em En | MEDLINE | ID: mdl-34737862
ABSTRACT

BACKGROUND:

Existing scores to identify children at risk of hospitalized pneumonia-related mortality lack broad external validation. Our objective was to externally validate three such risk scores.

METHODS:

We applied the Respiratory Index of Severity in Children (RISC) for HIV-negative children, the RISC-Malawi, and the Pneumonia Etiology Research for Child Health (PERCH) scores to hospitalized children in the Pneumonia REsearch Partnerships to Assess WHO REcommendations (PREPARE) data set. The PREPARE data set includes pooled data from 41 studies on pediatric pneumonia from across the world. We calculated test characteristics and the area under the curve (AUC) for each of these clinical prediction rules.

RESULTS:

The RISC score for HIV-negative children was applied to 3574 children 0-24 months and demonstrated poor discriminatory ability (AUC = 0.66, 95% confidence interval (CI) = 0.58-0.73) in the identification of children at risk of hospitalized pneumonia-related mortality. The RISC-Malawi score had fair discriminatory value (AUC = 0.75, 95% CI = 0.74-0.77) among 17 864 children 2-59 months. The PERCH score was applied to 732 children 1-59 months and also demonstrated poor discriminatory value (AUC = 0.55, 95% CI = 0.37-0.73).

CONCLUSIONS:

In a large external application of the RISC, RISC-Malawi, and PERCH scores, a substantial number of children were misclassified for their risk of hospitalized pneumonia-related mortality. Although pneumonia risk scores have performed well among the cohorts in which they were derived, their performance diminished when externally applied. A generalizable risk assessment tool with higher sensitivity and specificity to identify children at risk of hospitalized pneumonia-related mortality may be needed. Such a generalizable risk assessment tool would need context-specific validation prior to implementation in that setting.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Regras de Decisão Clínica Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Regras de Decisão Clínica Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article